IS4748A - Indól-2,3-díon-3-oxíms afleiður - Google Patents

Indól-2,3-díon-3-oxíms afleiður

Info

Publication number
IS4748A
IS4748A IS4748A IS4748A IS4748A IS 4748 A IS4748 A IS 4748A IS 4748 A IS4748 A IS 4748A IS 4748 A IS4748 A IS 4748A IS 4748 A IS4748 A IS 4748A
Authority
IS
Iceland
Prior art keywords
dione
het
oxime derivatives
indole
ring
Prior art date
Application number
IS4748A
Other languages
English (en)
Other versions
IS2123B (is
Inventor
Wätjen Frank
Drejer Jørgen
Original Assignee
Neurosearch A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch A/S filed Critical Neurosearch A/S
Publication of IS4748A publication Critical patent/IS4748A/is
Publication of IS2123B publication Critical patent/IS2123B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4748A 1996-10-01 1998-05-18 Indól-2,3-díon-3-oxíms afleiður IS2123B (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK106996 1996-10-01
DK127796 1996-11-13
PCT/DK1997/000418 WO1998014447A1 (en) 1996-10-01 1997-10-01 Novel indole-2,3-dione-3-oxime derivatives

Publications (2)

Publication Number Publication Date
IS4748A true IS4748A (is) 1998-05-18
IS2123B IS2123B (is) 2006-07-14

Family

ID=26065167

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4748A IS2123B (is) 1996-10-01 1998-05-18 Indól-2,3-díon-3-oxíms afleiður

Country Status (28)

Country Link
US (3) US6124285A (is)
EP (1) EP0869958B1 (is)
JP (1) JP3319762B2 (is)
KR (1) KR100492052B1 (is)
CN (1) CN1093859C (is)
AT (1) ATE286052T1 (is)
AU (1) AU716435B2 (is)
BG (1) BG63874B1 (is)
BR (1) BR9706765A (is)
CA (1) CA2238410C (is)
CZ (1) CZ297938B6 (is)
DE (1) DE69732090T2 (is)
DK (1) DK0869958T3 (is)
EE (1) EE9800144A (is)
ES (1) ES2235253T3 (is)
HU (1) HU225145B1 (is)
IL (1) IL124563A (is)
IS (1) IS2123B (is)
NO (1) NO310722B1 (is)
NZ (1) NZ330456A (is)
PL (1) PL193041B1 (is)
PT (1) PT869958E (is)
RU (1) RU2190612C2 (is)
SI (1) SI0869958T1 (is)
SK (1) SK282729B6 (is)
TR (1) TR199800956T1 (is)
UA (1) UA54403C2 (is)
WO (1) WO1998014447A1 (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму
JP2002509885A (ja) 1998-03-31 2002-04-02 ニューロサーチ、アクティーゼルスカブ 治療に使用するためのインドール−2,3−ジオン−3−オキシム誘導体
ATE420636T1 (de) * 1999-05-19 2009-01-15 Painceptor Pharma Corp Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen
JP2003520851A (ja) * 2000-01-24 2003-07-08 ニューロサーチ、アクティーゼルスカブ 神経栄養活性を有するイサチン誘導体
IT1318636B1 (it) * 2000-07-21 2003-08-27 Roberto Pellicciari Derivati dell'acido 2- o 3- tenoico ad attivita' antagonista deirecettori del glutammato.
JP2004523543A (ja) * 2001-02-15 2004-08-05 ニューロサーチ、アクティーゼルスカブ 神経栄養活性を有する化合物とドパミン活性を増加させる化合物の組み合わせ作用によるパーキンソン病の治療法
DE60206762T2 (de) 2001-07-13 2006-07-13 Pharmacia & Upjohn Co. Llc, Kalamazoo Hexahydroazepino(4,5-g)indole und -indoline als 5-ht rezeptor-liganden
US7632948B2 (en) 2002-08-22 2009-12-15 Neurosearch A/S Method of preparing enantiomers of indole-2,3-dione-3-oxime derivatives
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
CN101346375B (zh) * 2005-11-23 2013-04-10 阿罗斯药物有限责任公司 调节门离子通道用组合物和方法
CA2652307A1 (en) * 2006-04-10 2007-10-18 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2007115403A1 (en) * 2006-04-10 2007-10-18 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
US20100041691A1 (en) * 2006-09-12 2010-02-18 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
US20080108622A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
US20080108603A1 (en) * 2006-10-19 2008-05-08 Eisenach James C Combination therapy for the treatment of pain
WO2010104324A2 (ko) * 2009-03-10 2010-09-16 한국과학기술연구원 베타-아밀로이드 집적체 및 피브릴에 우수한 결합 친화도를 가지는 할로겐화 이소인돌론 화합물, 및 이의 제조 방법 및 용도
CN102653538A (zh) * 2011-03-04 2012-09-05 爱斯医药科技(南京)有限公司 Spd-502的制备方法
BR112017023038A2 (pt) 2015-04-29 2018-07-03 Janssen Pharmaceutica Nv imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa
KR20170140382A (ko) 2015-04-29 2017-12-20 얀센 파마슈티카 엔.브이. 아자벤즈이미다졸 및 ampa 수용체 조절제로서의 이의 용도
CA2984290C (en) 2015-04-29 2022-03-01 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
CN107750250B (zh) * 2015-04-29 2021-09-07 詹森药业有限公司 吲哚酮化合物及其作为ampa受体调节剂的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE69677B1 (en) * 1989-12-11 1996-10-02 Neurosearch As Isatine derivatives their preparation and use
MX9204914A (es) * 1991-08-28 1993-07-01 Frank Watjen Nuevos derivados de isatinoxima, metodo para su preparacion y composicion farmaceutica que los comprende.
JP3419539B2 (ja) * 1993-02-17 2003-06-23 中外製薬株式会社 インドリン−2−オン誘導体
US5721230A (en) 1993-05-10 1998-02-24 Hoffmann-La Roche Inc. Substituted pyrroles
CA2161783C (en) * 1993-05-13 2006-08-15 Frank Watjen Ampa antagonists and a method of treatment therewith
DK81593D0 (da) * 1993-07-07 1993-07-07 Neurosearch As Nye isatinoximderivater, deres fremstilling og anvendelse
NZ293266A (en) * 1994-09-14 1998-01-26 Neurosearch As Fused indole and quinoxaline dione and dione oxime derivatives, preparation and pharmaceutical compositions
US5917053A (en) * 1994-09-14 1999-06-29 Neurosearch A/S Indole-2,3-dione-3-oxime derivatives, their preparation and use
UA54403C2 (uk) * 1996-10-01 2003-03-17 Н'Юросерч А/С Похідні індол-2,3-діон-3-оксиму, фармацевтична композиція, спосіб лікування розладу чи захворювання ссавців, у тому числі людини та спосіб одержання похідних індол-2,3-діон-3-оксиму

Also Published As

Publication number Publication date
IS2123B (is) 2006-07-14
BG63874B1 (bg) 2003-04-30
CA2238410A1 (en) 1998-04-09
RU2190612C2 (ru) 2002-10-10
CN1093859C (zh) 2002-11-06
NO982466L (no) 1998-07-31
CZ297938B6 (cs) 2007-05-02
HUP9901630A2 (hu) 1999-08-30
JP2000501432A (ja) 2000-02-08
HUP9901630A3 (en) 2001-11-28
NO982466D0 (no) 1998-05-29
SK282729B6 (sk) 2002-11-06
NZ330456A (en) 1998-11-25
ATE286052T1 (de) 2005-01-15
IL124563A (en) 2005-05-17
DE69732090D1 (de) 2005-02-03
USRE38200E1 (en) 2003-07-22
HK1017682A1 (en) 1999-11-26
KR19990071823A (ko) 1999-09-27
AU4376897A (en) 1998-04-24
BG102489A (en) 1999-04-30
WO1998014447A1 (en) 1998-04-09
UA54403C2 (uk) 2003-03-17
ES2235253T3 (es) 2005-07-01
CN1207100A (zh) 1999-02-03
DK0869958T3 (da) 2005-04-18
EP0869958B1 (en) 2004-12-29
CA2238410C (en) 2007-06-12
AU716435B2 (en) 2000-02-24
EE9800144A (et) 1998-10-15
CZ160698A3 (cs) 1998-10-14
MX9804365A (es) 1998-10-31
JP3319762B2 (ja) 2002-09-03
PL193041B1 (pl) 2007-01-31
IL124563A0 (en) 1998-12-06
NO310722B1 (no) 2001-08-20
HU225145B1 (en) 2006-07-28
BR9706765A (pt) 1999-09-14
US6693111B1 (en) 2004-02-17
TR199800956T1 (xx) 1998-12-21
SK67698A3 (en) 1998-11-04
US6124285A (en) 2000-09-26
PT869958E (pt) 2005-05-31
DE69732090T2 (de) 2005-12-29
PL327073A1 (en) 1998-11-23
KR100492052B1 (ko) 2005-09-30
EP0869958A1 (en) 1998-10-14
SI0869958T1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
IS2123B (is) Indól-2,3-díon-3-oxíms afleiður
EA200100970A1 (ru) Аминопроизводные как ингибиторы протеазы
ATE157355T1 (de) 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
TW349098B (en) Naphthalene derivatives, process for the preparation thereof, and intermediates therefor
HUP0204418A2 (hu) NHE-1 inhibitor hatású N-[(helyettesített öttagú, di- vagy triaza-, kétszeresen telítetlen gyűrű)-karbonil]-guanidin-származékok és alkalmazásuk
NL980001I2 (nl) Therapeutische heterocyclische verbindingen.
ES2162466T3 (es) Derivados de 1,2,4-triazolo(4,3-b)pirido(3,2-d)piridazina y composiciones farmaceuticas que los contienen.
IL102703A (en) N-sulfonyl indoline derivatives carrying an amide functional group, their preparation and pharmaceutical compositions containing them
SE9103572D0 (sv) Organic salts of n,n'-diacetyl cystine
ATE282614T1 (de) Phenylharnstoff und phenylthioharnstoffderivate
DE69924292D1 (de) Pyrazol verbindungen und ihre verwendung
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
NO305287B1 (no) AMPA antagonister
ATE197305T1 (de) Endothelin antagonisten
ATE302772T1 (de) 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung
CO5140116A1 (es) Compuestos espiro derivados de imidazo-benzazepina con actividad antihistaminica y sus procesos de obtencion a partir de sus intermediarios de sintesis
IL91648A (en) Amino acid quinoline and naphthyridine derivatives, their preparation and pharmaceutical compositions containing them
EP1511765A4 (en) PEPTIDE-BY-2 PEPTIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION USING THE DERIVATIVE
AR019390A1 (es) Derivados de acidos sulfonilaminofosfinicos y sulfonilaminofosfonicos, procedimiento para su preparacion, compuestos intermediarios, medicamentos, procedimiento para su preparacion y empleo de dichos derivados para la preparacion de un medicamento.
AP2002002595A0 (en) Heterocyclic amide derivatives.
AR036554A1 (es) Coniosulfuros y sus derivados, procedimiento para su preparacion y su utilizacion como medicamentos
ES455436A1 (es) Procedimiento de preparacion de acidos tienotienilcarbonife-nilalcanoicos.
DE69108728D1 (de) [3H,7H]THIAZOLO[3,4-a]PYRIDINE MIT ANTIASTHMATISCHER UND ENTZÜNDUNGSHEMMENDER WIRKUNG AUF DIE ATMUNGSWEGE.
DK354681A (da) Fremgangsmaade til fremstilling af amidiner